Life Time Group Holdings (LTH)
(Delayed Data from NYSE)
$20.50 USD
-0.14 (-0.68%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $20.50 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth B Momentum A VGM
Life Time Group Holdings, Inc. (LTH) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$22.83 | $33.00 | $15.00 | 10.61% |
Price Target
Based on short-term price targets offered by 12 analysts, the average price target for Life Time Group Holdings, Inc. comes to $22.83. The forecasts range from a low of $15.00 to a high of $33.00. The average price target represents an increase of 10.61% from the last closing price of $20.64.
Analyst Price Targets (12)
Broker Rating
Life Time Group Holdings, Inc. currently has an average brokerage recommendation (ABR) of 1.75 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 12 brokerage firms. The current ABR compares to an ABR of 1.82 a month ago based on 11 recommendations.
Of the 12 recommendations deriving the current ABR, seven are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 58.33% and 8.33% of all recommendations. A month ago, Strong Buy made up 54.55%, while Buy represented 9.09%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 7 | 7 | 6 | 6 | 6 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 4 | 4 | 4 | 4 | 4 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.75 | 1.75 | 1.82 | 1.82 | 1.82 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/24/2024 | Northland Capital Markets | Owen Rickert | Strong Buy | Strong Buy |
7/19/2024 | Craig-Hallum | Alex J Fuhrman | Not Available | Strong Buy |
5/2/2024 | Wells Fargo Securities | Daniel Politzer | Hold | Hold |
4/25/2024 | Not Identified | Not Identified | Not Available | Moderate Buy |
3/5/2024 | BMO Capital Markets | Simeon Siegel | Hold | Hold |
3/4/2024 | Mizuho SecuritiesUSA | John J Baumgartner | Strong Buy | Strong Buy |
1/2/2024 | Guggenheim Securities | John Edward Heinbockel | Strong Buy | Strong Buy |
10/26/2023 | Goldman Sachs | Katharine A Mcshane | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.75 |
ABR (Last week) | 1.75 |
# of Recs in ABR | 12 |
Average Target Price | $22.83 |
LT Growth Rate | 12.20% |
Industry | Medical Services |
Industry Rank by ABR | 93 of 252 |
Current Quarter EPS Est: | 0.16 |